NRX PHARMACEUTICALS INC - COM (NRXP)

CUSIP: 629444100

Q4 2022 13F Holders as of 31 Dec 2022

Share change
-1,036,130
Put/Call ratio
18%
SEC-reported price per share
$1.11
Number of holders
30
Value change
-$784,927
Number of buys
17
Open additional details 1 more signal available
Number of sells
12

Security key

629444100

Report period

Q4 2022

Institutions

30

Top holders

10

Ownership snapshot

Top reported holders of NRXP - NRX PHARMACEUTICALS INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Daniel C. Javitt
Disclosed value leader
Daniel C. Javitt
Comparable rows
0/15
Latest evidence
29 Nov 2022
3/4/5 13F Highest disclosed value: $3,082,170 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Daniel C. Javitt has the largest disclosed position value at $3.08M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Daniel C. Javitt's linked filing trail.
Disclosed position value Top 5
Daniel C. Javitt $3.08M
BRAC Lending Group LLC $188.9K
Big Rock Partners Sponsor, LLC $166.1K
VANGUARD GROUP INC $1.06M
JPMORGAN CHASE & CO $650K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Daniel C. Javitt
3/4/5
10%+ Owner
—
denominator unverified
$3,082,170
9,634,793 shares
— 29 Nov 2022
BRAC Lending Group LLC
3/4/5
10%+ Owner
—
denominator unverified
$188,880
590,435 shares
— 24 May 2021
Big Rock Partners Sponsor, LLC
3/4/5
10%+ Owner
—
mixed-class rows
$166,129
619,315 shares
mixed-class rows
— 24 May 2021
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$1,065,000
1,440,265 shares
— 30 Sep 2022
JPMORGAN CHASE & CO
13F
Company
13F
—
denominator unverified
$650,000
878,961 shares
— 30 Sep 2022
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$480,000
648,538 shares
— 30 Sep 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
30
Shares
3,096,298
Rows available
30
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders
25
Q4 2022 holders
30
Holder diff
5
Investor Q3 2022 Shares Q4 2022 Shares Share Diff Share Chg % Q3 2022 value Q4 2022 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .